The new SPAC intends to focus on companies in the life sciences industry with a primary focus on novel therapeutics, medical devices, or services that help improve healthcare outcomes. OPY Acquisition Corp. I is led by Chairman and CEO Jonathan B. Siegel, and CFO Daniel E. Geffken.
Total SPAC deal count for 2021 year-to-date is now 494. This offering is expected to close on Friday, October 29.
Oppenheimer & Co. and Lake Street are serving as the joint book-running managers for the offering. Loeb & Loeb LLP is serving as Issuer’s Counsel with White & Case LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.